LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) | NCT04344002

Status Module

Oversight Module

Description Module

Design Module

Interventional Study Design

Biospecimen

No data available

No data is available for this block.

Label	Type	Description	Intervention Names
lung cancer+COVID-19		lung cancer patients diagnosed with COVID-19

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Clinical data of lung cancer patients with COVID-19 diagnoses	Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data.	From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Diagnosis data	Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis	From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Treatments received	Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received	From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Prognostic factors	Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors.	From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years

Eligibility Module

Contacts/Locations Module

Overall Officials

Name	Affiliation	Role
Mariano MD Provencio, MD	Hospital Puerta de Hierro de Majadahonda de Madrid	Study Chair
Cristina MD Avendaño Solá, MD	Hospital Puerta de Hierro de Majadahonda de Madrid	Study Chair
María MD González-Cao, MD	Hospital Universitario Dexeus de Barcelona.	Study Chair

Facility	Status	City	State	ZIP	Country	Contacts
Complejo Hospitalario Universitario de Ferrol		Ferrol	A Coruña		Spain
H. Clínica Benidorm

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
36566266	Derived	Gonzalez-Cao M, Puertolas T, Martinez-Vila C, Carrera C, Maldonado Seral C, Rodriguez-Jimenez P, Sequero S, Cerezuela-Fuentes P, Feltes Ochoa R, Munoz E, Antonanzas Basa M, Martin-Liberal J, Soria A, Francisco Rodriguez Moreno J, Marquez-Rodas I, Lopez Criado P, Luis Manzano J, Lopez-Castro R, Ayala de Miguel P, Villalobos L, Martin Algarra S, Gonzalez-Barrallo I, Boada A, Garcia Castano A, Puig S, Crespo G, Luna Fra P, Aguayo Zamora C, Feito Rodriguez M, Valles L, Drozdowskyj A, Gardeazabal J, Antonio Fernandez-Morales L, Rodrigo A, Cruz R, Yelamos O, Rubio B, Mujica K, Provencio M, Berrocal A; Spanish Melanoma Group (GEM). SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry. Clin Transl Oncol. 2023 Mar;25(3):768-775. doi: 10.1007/s12094-022-02985-7. Epub 2022 Dec 24.

Label	URL
Web page of the sponsor where users can find more information about Fundacion GECP studies	View source

Ancestor Terms

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D007239	Infections
D014777	Virus Diseases
D003333	Coronaviridae Infections
D030341	Nidovirales Infections
D012327	RNA Virus Infections
D008171	Lung Diseases
D012140	Respiratory Tract Diseases
D012142	Respiratory Tract Neoplasms
D013899	Thoracic Neoplasms
D009371	Neoplasms by Site
D009369	Neoplasms